SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics PLC, a company dedicated to skin health, has announced the appointment of Dr. Surinder ‘Dass’ Chahal, a former senior Croda Vice President with over 37 years of industry experience, as their Cosmetic Science / Customer Alliances Advisor. Dr. Chahal’s role will bridge the company with Croda during the commercialization phase and offer strategic advice in cosmetic science and partnerships. The move is expected to bolster SkinBioTherapeutics’ advisory team as they develop and commercialize their skin healthcare technologies.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
